|
TDRD7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26619945031814E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.19047002758543E-13 |
| Normal-vs-Stage2 |
4.44360000000366E-05 |
| Normal-vs-Stage3 |
5.996500E-03 |
| Normal-vs-Stage4 |
1.622100E-02 |
| Stage1-vs-Stage2 |
9.393000E-01 |
| Stage1-vs-Stage3 |
2.444000E-04 |
| Stage1-vs-Stage4 |
1.303870E-03 |
| Stage2-vs-Stage3 |
2.166400E-02 |
| Stage2-vs-Stage4 |
3.488100E-02 |
| Stage3-vs-Stage4 |
9.971400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55039980853644E-10 |
| Normal-vs-AfricanAmerican |
1.255700E-02 |
| Normal-vs-Asian |
3.546200E-02 |
| Caucasian-vs-AfricanAmerican |
1.057830E-01 |
| Caucasian-vs-Asian |
2.253600E-01 |
| AfricanAmerican-vs-Asian |
5.264300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75749999997699E-07 |
| Normal-vs-Female |
8.30302493426416E-12 |
| Male-vs-Female |
6.278500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.731800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.39079994585256E-10 |
| Normal-vs-Age(61-80Yrs) |
9.10040000023926E-08 |
| Normal-vs-Age(81-100Yrs) |
2.262400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.687600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.469600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.802800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.438400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.204800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.020600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.0320000034616E-08 |
| Normal-vs-Grade 2 |
8.53761505936745E-14 |
| Normal-vs-Grade 3 |
3.32579999984262E-07 |
| Normal-vs-Grade 4 |
6.345200E-01 |
| Grade 1-vs-Grade 2 |
1.709200E-01 |
| Grade 1-vs-Grade 3 |
5.082300E-03 |
| Grade 1-vs-Grade 4 |
3.49060000004453E-06 |
| Grade 2-vs-Grade 3 |
8.016900E-03 |
| Grade 2-vs-Grade 4 |
9.25950000008058E-08 |
| Grade 3-vs-Grade 4 |
1.017070E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.921800E-01 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.71060002116275E-09 |
| Normal-vs-N1 |
1.239350E-01 |
| N0-vs-N1 |
6.324600E-01 |
|
|
